UN urges broader access to drugs
BMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i5017 (Published 15 September 2016) Cite this as: BMJ 2016;354:i5017- Anne Gulland
- London
Drug companies and governments must do more to ensure access to drugs among the world’s poorest people, a United Nations report has urged.
The final report of the UN secretary general’s high level panel on access to medicines said that despite the improvements brought by medical innovation in the field of vaccines and antiretroviral drugs for HIV/AIDS over the past few decades, “millions of people continue to suffer and die from treatable conditions because of a lack of access to health technologies.”1
It said that investment in research and development (R&D) did not adequately …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.